EBS
Emergent BioSolutions Inc.
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · US
$6.20
−0.56%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 17.34x
- P/E 2027E
- 5.96x
- P/E 2028E
- 3.98x
- P/S forward
- 0.49x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.93x
- Price / sales
- 0.41x
- Price / cash flow
- 3.25x
Enterprise value
- Enterprise value
- $759.7M
- EV / sales
- 0.99x
- EV / EBITDA
- -32.06x
- EV / EBIT
- -13.97x
- Market cap
- $317.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026